Skip to main content

Imfinzi 120 mg/2.4 mL injection Images

Generic Name: durvalumab

This medication has been identified as Imfinzi 120 mg/2.4 mL injection. It is supplied by AstraZeneca.

Imfinzi is used in the treatment of Non-Small Cell Lung Cancer; Small Cell Lung Cancer; Biliary Tract Tumor and belongs to the drug class anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors). Imfinzi 120 mg/2.4 mL injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Imfinzi 120 mg/2.4 mL injection medicine

Imfinzi

Generic Name
durvalumab
Strength
120 mg/2.4 mL injection
Availability
Prescription only
Drug Class
Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
CSA Schedule
Not a controlled drug
Labeler / Supplier
AstraZeneca
National Drug Code (NDC)
00310-4500

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.